SII Commences ‘Covovax’ Trials In India
Expected Launch By September, 2021 Serum Institute of India (SII), the world’s largest manufacturer of vaccines by volume and the biggest Covid-19 vaccine maker, is looking to launch the ‘Covovax’ vaccine – developed in partnership with American vaccine developer Novavax, by September 2021, announced CEO Adar Poonawalla, on 27th March, 2021. Adar added that the Covid-19 vaccine…